| Huntington disease NS Caron, GEB Wright, MR Hayden GeneReviews®[Internet], 2020 | 217* | 2020 |
| Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease GEB Wright, JA Collins, C Kay, C McDonald, E Dolzhenko, Q Xia, ... The American Journal of Human Genetics 104 (6), 1116-1126, 2019 | 186 | 2019 |
| Nuclear receptor NR1H3 in familial multiple sclerosis Z Wang, AD Sadovnick, AL Traboulsee, JP Ross, CQ Bernales, ... Neuron 90 (5), 948-954, 2016 | 122 | 2016 |
| Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation L Warnich, B I Drogemoller, M S Pepper, C Dandara, G EB Wright Current Pharmacogenomics and Personalized Medicine 9 (3), 191-207, 2011 | 92 | 2011 |
| Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS ABP van Kuilenburg, M Tarailo-Graovac, PA Richmond, BI Drögemöller, ... New England Journal of Medicine 380 (15), 1433-1441, 2019 | 91 | 2019 |
| The global spectrum of protein-coding pharmacogenomic diversity GEB Wright, B Carleton, MR Hayden, CJD Ross The Pharmacogenomics Journal 18, 187–195, 2018 | 82 | 2018 |
| Ethical and legal implications of whole genome and whole exome sequencing in African populations GEB Wright, PGJ Koornhof, AA Adeyemo, N Tiffin BMC Medical Ethics 14 (1), 21, 2013 | 79 | 2013 |
| The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population C Kay, JA Collins, GEB Wright, F Baine, Z Miedzybrodzka, F Aminkeng, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018 | 77 | 2018 |
| Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ... Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019 | 73 | 2019 |
| Characterization of the Genetic Profile of CYP2C19 in Two South African Populations BI Drögemöller, GEB Wright, DJH Niehaus, L Koen, S Malan, DM Da Silva, ... Pharmacogenomics 11 (8), 1095-1103, 2010 | 66 | 2010 |
| Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population GEB Wright, DJH Niehaus, BI Drögemöller, L Koen, A Gaedigk, L Warnich Annals of Human Genetics 74 (4), 340-350, 2010 | 66 | 2010 |
| Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies GEB Wright, HF Black, JA Collins, T Gall-Duncan, NS Caron, CE Pearson, ... The Lancet Neurology 19 (11), 930-939, 2020 | 64 | 2020 |
| SJS/TEN 2019: from science to translation WC Chang, R Abe, P Anderson, W Anderson, MR Ardern-Jones, ... Journal of dermatological science 98 (1), 2-12, 2020 | 63 | 2020 |
| Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ... JAMA Oncology 3 (11), 1558-1562, 2017 | 60 | 2017 |
| Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study TM Dodgen, WE Hochfeld, H Fickl, SM Asfaha, C Durandt, P Rheeder, ... BMC Medical Genetics 14 (1), 20, 2013 | 54 | 2013 |
| Characterization of the genetic variation present in CYP3A4 in three South African populations BI Drögemöller, M Plummer, L Korkie, G Agenbag, A Dunaiski, D Niehaus, ... Frontiers in Genetics 4, 17, 2013 | 54 | 2013 |
| A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping D Twesigomwe, GEB Wright, BI Drögemöller, J Da Rocha, Z Lombard, ... NPJ genomic medicine 5 (1), 30, 2020 | 48 | 2020 |
| Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients BI Drögemöller, B Brooks, C Critchley, JG Monzon, GEB Wright, G Liu, ... Clinical Cancer Research 24 (8), 1866-1871, 2018 | 48 | 2018 |
| Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients M McCormack, H Gui, A Ingason, D Speed, GEB Wright, EJ Zhang, ... Neurology 90 (4), e332-e341, 2018 | 48 | 2018 |
| A systematic review and analysis of the use of polygenic scores in pharmacogenomics D Johnson, MKAP Wilke, SM Lyle, K Kowalec, A Jorgensen, GEB Wright, ... Clinical Pharmacology & Therapeutics 111 (4), 919-930, 2022 | 47 | 2022 |
Colin RossUniversity of British Columbia, Pharmaceutical SciencesVerified email at ubc.ca
